CERN:NSD-Cerner Corp (USD)

COMMON STOCK | Health Information Services | NSD

Last Closing Price

USD 94.92

Change

0.00 (0.00)%

Market Cap

USD 27.92B

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


CERN Stock Forecast & Price:
Based on the Cerner Corp stock forecasts from 1 analysts, the average analyst target price for Cerner Corp is USD 0.00 over the next 12 months. Cerner Corp’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Cerner Corp is Bullish , which is based on 4 positive signals and 1 negative signals. At the last closing, Cerner Corp’s stock price was USD 94.92. Cerner Corp’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +20.00% over the last year.

About Cerner Corp (CERN:NSD)

Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. It offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, f ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-10 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CHNG Change Healthcare Inc

+0.29 (+1.19%)

USD7.73B N/A 15.20
RCM R1 RCM Inc

+0.33 (+1.28%)

USD7.43B 43.55 35.15
INOV Inovalon Holdings Inc

N/A

USD6.37B 122.57 33.93
HQY HealthEquity Inc

-0.11 (-0.18%)

USD5.16B 789.30 55.52
TXG 10X Genomics Inc

+2.00 (+4.45%)

USD4.83B N/A -81.27
OMCL Omnicell Inc

+2.09 (+1.99%)

USD4.65B 71.59 33.83
PINC Premier Inc

+0.60 (+1.58%)

USD4.48B 15.94 10.44
PGNY Progyny Inc

+4.02 (+9.84%)

USD4.02B 56.73 133.27
CERT Certara Inc

-2.48 (-10.86%)

USD3.79B N/A 61.27
HMSY HMS Holdings Corp

N/A

USD3.29B 47.40 23.59

ETFs Containing CERN

Symbol Name Weight Mer Price(Change) Market Cap
TPLC Timothy Plan US Large/Mid.. 0.00 % 0.52 %

+0.74 (+2.17%)

USD0.17B
OSX2:F Ossiam Lux - Ossiam US Mi.. 0.00 % 0.65 %

+1.10 (+0.42%)

N/A
5HEE:XETRA Ossiam ESG Low Carbon Shi.. 0.00 % 0.75 %

+0.94 (+0.88%)

USD0.37B
EDOC Global X Telemedicine & D.. 0.00 % 0.68 %

+0.71 (+5.59%)

N/A
TPLE Timothy Plan - Timothy Pl.. 0.00 % 0.52 %

+0.14 (+0.56%)

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.21% N/A N/A N/A N/A
Dividend Return 0.29% N/A N/A N/A N/A
Total Return 2.50% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 19.43% N/A N/A N/A N/A
Dividend Return 0.96% N/A N/A N/A N/A
Total Return 20.38% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 52.83% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.83% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.44% 47% F 62% D-
Dividend Return 0.79% 56% F 22% F
Total Return 9.23% 50% F 61% D-
Risk Return Profile  
Volatility (Standard Deviation) 14.53% 88% B+ 78% C+
Risk Adjusted Return 63.50% 79% C+ 87% B+
Market Capitalization 27.92B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 48.06 N/A N/A N/A N/A
Price/Book Ratio 7.07 N/A N/A N/A N/A
Price / Cash Flow Ratio 15.76 N/A N/A N/A N/A
EV/EBITDA 18.97 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 14.34% N/A N/A N/A N/A
Return on Invested Capital 9.96% N/A N/A N/A N/A
Return on Assets 9.18% N/A N/A N/A N/A
Debt to Equity Ratio 43.78% N/A N/A N/A N/A
Technical Ratios  
Dividend Yield 1.14% N/A N/A N/A N/A
Short Ratio 3.21 N/A N/A N/A N/A
Short Percent 3.47% N/A N/A N/A N/A
Beta 0.76 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.